CUSIP G76279101 · who reports it, how much, and how much it matters to them
45 of the 720 hedge fund managers we track reported shares of Roivant Sciences Ltd. (Nasdaq: ROIV) on Form 13F for 30 June 2026. Between them they reported USD 2.6bn. The largest position belongs to Farallon Capital Management, at USD 506m. The manager with the most riding on it is Whitefort Capital Management, where it is 8.9% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Farallon Capital Management56 funds on PPLI.com | USD 506m | 2.3% |
| 2 | Adage Capital Management1 fund on PPLI.com | USD 366m | 0.5% |
| 3 | Perceptive Advisors6 funds on PPLI.com | USD 286m | 4.3% |
| 4 | Viking Global Investors4 funds on PPLI.com | USD 222m | 0.6% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 197m | 0.0% |
| 6 | Baker Bros. Advisors2 funds on PPLI.com | USD 167m | 0.8% |
| 7 | POINT72 Asset Management17 funds on PPLI.com | USD 158m | 0.2% |
| 8 | D. E. Shaw & Co.15 funds on PPLI.com | USD 105m | 0.1% |
| 9 | Maverick Capital20 funds on PPLI.com | USD 100m | 0.9% |
| 10 | Weiss Asset Management5 funds on PPLI.com | USD 90m | 0.9% |
| 11 | Dme Capital Management7 funds on PPLI.com | USD 76m | 1.9% |
| 12 | Blackbarn Capital Partners1 fund on PPLI.com | USD 71m | 6.0% |
| 13 | Marshall Wace LLP84 funds on PPLI.com | USD 50m | 0.0% |
| 14 | Polar Capital LLP26 funds on PPLI.com | USD 49m | 0.1% |
| 15 | Whitefort Capital Management1 fund on PPLI.com | USD 36m | 8.9% |
| 16 | Millennium Management6 funds on PPLI.com | USD 25m | 0.0% |
| 17 | Brevan Howard Capital Management39 funds on PPLI.com | USD 18m | 0.1% |
| 18 | Jain Global1 fund on PPLI.com | USD 17m | 0.1% |
| 19 | Squarepoint Ops7 funds on PPLI.com | USD 17m | 0.0% |
| 20 | Cormorant Asset Management1 fund on PPLI.com | USD 17m | 0.9% |
| 21 | PFM Health Sciences3 funds on PPLI.com | USD 9.5m | 0.8% |
| 22 | Cinctive Capital Management5 funds on PPLI.com | USD 8m | 0.3% |
| 23 | Atika Capital Management3 funds on PPLI.com | USD 7.7m | 0.5% |
| 24 | Artia Global Partners1 fund on PPLI.com | USD 4.6m | 0.8% |
| 25 | Prelude Capital Management9 funds on PPLI.com | USD 4m | 0.3% |
| 26 | Rock Springs Capital Management2 funds on PPLI.com | USD 3.6m | 0.2% |
| 27 | Walleye Capital8 funds on PPLI.com | USD 3.5m | 0.0% |
| 28 | Platinum Investment Management11 funds on PPLI.com | USD 3.3m | 0.8% |
| 29 | Edgestream Partners5 funds on PPLI.com | USD 2.9m | 0.1% |
| 30 | Boothbay Fund Management2 funds on PPLI.com | USD 2.8m | 0.0% |
| 31 | Fora Capital1 fund on PPLI.com | USD 1.6m | 0.1% |
| 32 | Capricorn Fund Managers8 funds on PPLI.com | USD 1.4m | 0.1% |
| 33 | Hudson Bay Capital Management8 funds on PPLI.com | USD 1.2m | 0.0% |
| 34 | LMR Partners2 funds on PPLI.com | USD 1.2m | 0.0% |
| 35 | Superstring Capital Management1 fund on PPLI.com | USD 907,000 | 0.6% |
| 36 | Two Sigma Investments35 funds on PPLI.com | USD 779,000 | 0.0% |
| 37 | Capital Fund Management S.A.12 funds on PPLI.com | USD 679,000 | 0.0% |
| 38 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 569,000 | 0.0% |
| 39 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 435,000 | 0.0% |
| 40 | Persistent Asset Partners10 funds on PPLI.com | USD 390,000 | 0.1% |
| 41 | Capstone Investment Advisors25 funds on PPLI.com | USD 258,000 | 0.0% |
| 42 | Entrypoint Capital1 fund on PPLI.com | USD 253,000 | 0.1% |
| 43 | Scientech Research2 funds on PPLI.com | USD 248,000 | 0.2% |
| 44 | Bayforest Capital1 fund on PPLI.com | USD 84,511 | 0.1% |
| 45 | The Quarry1 fund on PPLI.com | USD 65,755 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Whitefort Capital Management | USD 36m | 8.9% |
| 2 | Blackbarn Capital Partners | USD 71m | 6.0% |
| 3 | Perceptive Advisors | USD 286m | 4.3% |
| 4 | Farallon Capital Management | USD 506m | 2.3% |
| 5 | Dme Capital Management | USD 76m | 1.9% |
| 6 | Weiss Asset Management | USD 90m | 0.9% |
| 7 | Maverick Capital | USD 100m | 0.9% |
| 8 | Cormorant Asset Management | USD 17m | 0.9% |
| 9 | Artia Global Partners | USD 4.6m | 0.8% |
| 10 | Baker Bros. Advisors | USD 167m | 0.8% |
Roivant Sciences Ltd. trades under the symbol ROIV on the Nasdaq. Its CUSIP, the code used on Form 13F, is G76279101.
45 of the 720 hedge fund managers PPLI.com tracks reported Roivant Sciences Ltd. shares on Form 13F for 30 June 2026. The largest reported positions were held by Farallon Capital Management (USD 506m), Adage Capital Management (USD 366m), Perceptive Advisors (USD 286m), Viking Global Investors (USD 222m) and Citadel Advisors (USD 197m).
45 managers in our coverage reported it, and between them they run 525 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Whitefort Capital Management, where the position was 8.9% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Roivant Sciences Ltd. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.